On Monday, the U.S.
After a bitter seven-year battle between the Broad and Doudna and Charpentier’s side, known as the CVC group, the patent judges finally issued a definitive opinion on who invented the “guide RNA” molecule that allows the genome editor to work in eukaryotic cells.